Modulators of 14-3-3 Protein–Protein Interactions
Document type :
Article dans une revue scientifique
Permalink :
Title :
Modulators of 14-3-3 Protein–Protein Interactions
Author(s) :
Stevers, Loes M. [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Sijbesma, Eline [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Botta, Maurizio [Auteur]
Università degli Studi di Siena = University of Siena [UNISI]
MacKintosh, Carol [Auteur]
University of Dundee
Obsil, Tomas [Auteur]
Landrieu, Isabelle [Auteur]
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Cau, Ylenia [Auteur]
Università degli Studi di Siena = University of Siena [UNISI]
Wilson, Andrew J. [Auteur]
University of Leeds
Karawajczyk, Anna [Auteur]
Eickhoff, Jan [Auteur]
Davis, Jeremy [Auteur]
Hann, Michael [Auteur]
GlaxoSmithKline [Stevenage, UK] [GSK]
O’Mahony, Gavin [Auteur]
AstraZeneca
Doveston, Richard G. [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Brunsveld, Luc [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Ottmann, Christian [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Eindhoven University of Technology [Eindhoven] [TU/e]
Sijbesma, Eline [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Botta, Maurizio [Auteur]
Università degli Studi di Siena = University of Siena [UNISI]
MacKintosh, Carol [Auteur]
University of Dundee
Obsil, Tomas [Auteur]
Landrieu, Isabelle [Auteur]

Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Cau, Ylenia [Auteur]
Università degli Studi di Siena = University of Siena [UNISI]
Wilson, Andrew J. [Auteur]
University of Leeds
Karawajczyk, Anna [Auteur]
Eickhoff, Jan [Auteur]
Davis, Jeremy [Auteur]
Hann, Michael [Auteur]
GlaxoSmithKline [Stevenage, UK] [GSK]
O’Mahony, Gavin [Auteur]
AstraZeneca
Doveston, Richard G. [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Brunsveld, Luc [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Ottmann, Christian [Auteur]
Eindhoven University of Technology [Eindhoven] [TU/e]
Journal title :
Journal of medicinal chemistry
Volume number :
61
Pages :
3755-3778
Publication date :
2017-10-19
ISSN :
0022-2623
English keyword(s) :
Peptides and proteins
Monomers
Crystal structure
Inhibitors
Inhibition
Monomers
Crystal structure
Inhibitors
Inhibition
HAL domain(s) :
Chimie/Chimie théorique et/ou physique
English abstract : [en]
Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein–protein interactions (PPIs) has now been widely recognized as an ...
Show more >Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein–protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as “undruggable” targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.Show less >
Show more >Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein–protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as “undruggable” targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CNRS
Université de Lille
Université de Lille
Research team(s) :
RMN et interactions moléculaires
Submission date :
2020-02-12T15:45:01Z
2021-07-13T12:28:08Z
2021-07-13T12:30:44Z
2021-07-13T12:28:08Z
2021-07-13T12:30:44Z
Files
- acs.jmedchem.7b00574.pdf
- Version éditeur
- Open access
- Access the document
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States